FierceBiotech ٢٣ ديسمبر ٢٠٢٥ Edwards nets FDA approval for Sapien M3 transcatheter mitral valve replacement
FierceBiotech ٢٦ نوفمبر ٢٠٢٥ FTC outlines antitrust case against Edwards' $945M JenaValve acquisition